COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India
To treat COVID-19 patients, US Food and Drug Administration gave Eli Lilly an emergency use approval for baricitinib in combination with remdesivir last year
from Top India News- News18.com https://ift.tt/3vXqw0b
via IFTTT
from Top India News- News18.com https://ift.tt/3vXqw0b
via IFTTT
No comments